The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive Bladder

年龄、性别和残余尿量对使用A型肉毒杆菌毒素治疗膀胱过度活动症后导尿率的影响

阅读:1

Abstract

BACKGROUND: Transient increases in postvoid residual urine volume (PVR) requiring clean intermittent catheterization (CIC) have occurred with onabotulinumtoxinA treatment for overactive bladder (OAB). OBJECTIVE: To evaluate onabotulinumtoxinA safety and the effect of age, gender, and maximum PVR (PVR(max)) on CIC initiation in adults with OAB and urinary incontinence (UI). DESIGN SETTING AND PARTICIPANTS: This was a pooled post hoc analysis of four placebo-controlled, multicenter randomized trials that included adults with idiopathic OAB after first onabotulinumtoxinA treatment (NCT00910845, NCT00910520, NCT01767519, NCT01945489). Patients had at least three urgency UI episodes over 3 d and at least eight micturitions per day, had inadequate management with at least one anticholinergic agent, and were willing to use CIC. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We measured the following outcomes: PVR(max) within 12 wk after first treatment; CIC incidence; estimated functional capacity; PVR ratio (PVR/estimated functional capacity). RESULTS AND LIMITATIONS: Of 1504 patients, 87.7% were women and 88.8% were White. The mean age was 60.5 yr across 10-yr age groups, baseline PVR was 13.8-35.0 ml, and estimated functional capacity was 293.5-475.7 ml. Mean baseline PVR was 21.3 ml overall versus 34.0 ml in the group that started CIC. The CIC incidence was 6.2% for women (range 1.1-8.4%) and 10.5% for men (range 0-14.6%). Higher CIC rates were observed for PVR(max) >350 ml (women 91.9%, men 84.6%) in comparison to PVR(max) of 201-350 ml (women 32.5%, men 17.4%) and PVR(max) <200 ml (women 1.2%, men 1.6%). Overall, 2/1504 patients (both women) were unable to void spontaneously. The mean PVR ratio was highest at week 2. Some subgroups had small sample sizes. CONCLUSIONS: CIC incidence was low overall, was less frequent for women, was rare with PVR(max) ≤200 ml, and did not appear to correlate with baseline PVR. PATIENT SUMMARY: After onabotulinumtoxinA treatment for OAB, patients sometimes insert a catheter to help in emptying their bladder after urinating. In this study, few patients needed a catheter, especially when less urine volume remained after urination.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。